Caricamento...
Anti‐PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care
OBJECTIVES: To put data from our recent systematic review of phase 3 studies of anti‐proprotein convertase subtilisin/kexin type 9 (PCSK9) antibodies into the context of clinical practice. METHODS: Data from studies previously identified by a systematic review of phase 3 studies of alirocumab and ev...
Salvato in:
| Pubblicato in: | Int J Clin Pract |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5601297/ https://ncbi.nlm.nih.gov/pubmed/28750477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12979 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|